<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/8809</identifier>
				<datestamp>2024-05-03T23:13:46Z</datestamp>
				<setSpec>bovine:RA</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Effects of parenteral or intranasal modified-live virus respiratory vaccination and revaccination on day 14 in auction-derived feedlot heifers</dc:title>
	<dc:creator xml:lang="en">Auchard, Erica</dc:creator>
	<dc:creator xml:lang="en">Hardee, Deana V.</dc:creator>
	<dc:creator xml:lang="en">Koers, Wally C.</dc:creator>
	<dc:creator xml:lang="en">Davis, Shane</dc:creator>
	<dc:creator xml:lang="en">Parks, Tim R.</dc:creator>
	<dc:creator xml:lang="en">Richeson, John T.</dc:creator>
	<dc:subject xml:lang="en">intranasal</dc:subject>
	<dc:subject xml:lang="en">parenteral</dc:subject>
	<dc:subject xml:lang="en">vaccination</dc:subject>
	<dc:subject xml:lang="en">bovine respiratory</dc:subject>
	<dc:description xml:lang="en">Auction-derived beef heifers were received in 12 arrival blocks and randomized to 4 treatment groups: 1) parenteral MLV vacci­nation on d 0 (INJ), 2) intranasal MLV vaccination on d 0 (INT), 3) parenteral MLV vaccination on d 0 and revaccination with intranasal on d 14 (INJ-R), 4) intranasal MLV vaccination on d 0 and revaccination with intranasal on d 14 (INT-R). Pen was experimental unit, with 12 pens/treatment and 65 to 76 heif­ers/pen in a randomized complete block design. Performance, health, carcass traits and BRSV and H. somni frequency of car­riage in the nasopharynx of revaccinated groups on d 0 and 60 was determined. Morbidity (P = 0.95), mortal­ity (P = 0.80), and other health variables (P &amp;gt; 0.74) did not dif­fer. However, an improvement in gain-to-feed (G:F) (P = 0.04), increased ribeye area (REA) (P ≤ 0.01) and percentage of edible livers (P ≤ 0.01) was observed for INJ and INJ-R. The BRSV (P = 0.09) and H. somni (P &amp;lt; 0.01) frequency of carriage in the naso­pharynx increased with time but no treatment effect (P ≥ 0.23) nor treatment x day interaction (P ≥ 0.29) existed. Revaccina­tion with an intranasal MLV did not impact health or growth, and arrival intranasal vaccination (INT and INT-R) resulted in less G:F and REA concomitant with increased liver absces­sation, compared to parenteral (INJ and INJ-R). Detection of H. somni in the nasopharynx was frequent on d 60, suggesting important prevalence of this bacterial pathogen in the south­ern U.S. cattle population.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2024-02-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8809</dc:identifier>
	<dc:identifier>10.21423/bovine-vol58no1p33-40</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 58 No. 1 (2024); 33-40</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8809/8537</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
